MENU
ITOS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
iTeos Therapeutics (ITOS) Ownership - Who owns iTeos Therapeutics?
ITeos Therapeutics Inc is a biopharmaceutical company... Show more
Profile
Industry
N/A
Address
321 Arsenal Street
Phone
+1 339 217-0162
Employees
157
Web
https://www.iteostherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
220.38M
P/E Ratio
N/A
Total Cash
494.65M
Projected Growth
N/A
Total Debt
5.1M
Revenue
35M
Risk (Beta)
1.04
Dividend Yield
N/A
Total Cash/Share
12.95
Total Debt/Equity
N/A
Revenue/Share
0.86 USD as % of share price
Fundamentals
ITOS
Capitalization
220M
P/E Ratio
N/A
Risk (Beta)
1.04
Dividend Yield
N/A
Total Cash
495M
Total Cash/Share
12.95
Total Debt
5.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.86%
Revenue
35M
ROE
N/A
Book Value
590M
P/B Ratio
0.37
Cash Flow
N/A
Earnings
-3.32
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
37K
Current Ratio
12.62
Current Revenue Per Employee
222929.94
Dividends Per Share - Security
N/A
EBITDA
-153.09M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-19.85
Shares Held By Institutions
388M
Shares Outstanding - Current
38.2M
Total Liabilities
96.7M
Total Volume MTD
N/A
Value
-1
Gain YTD
-24.870
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the development of biopharmaceuticals therapeutic products and services
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
321 Arsenal Street
Phone
+1 339 217-0162
Employees
157
Web
https://www.iteostherapeutics.com